Asset Details
Do you wish to reserve the book?
The Epidemiology of Neuroendocrine Carcinomas in Taiwan: A Population‐Based Cancer Registry Study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Epidemiology of Neuroendocrine Carcinomas in Taiwan: A Population‐Based Cancer Registry Study
Do you wish to request the book?
The Epidemiology of Neuroendocrine Carcinomas in Taiwan: A Population‐Based Cancer Registry Study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Epidemiology of Neuroendocrine Carcinomas in Taiwan: A Population‐Based Cancer Registry Study
2025
Overview
Background Lung and small cell neuroendocrine carcinomas (SCCs) are the most common sites and histological types of high‐grade neuroendocrine carcinoma (NEC). Comprehensive epidemiological information on NECs is limited. We used the Taiwan Cancer Registry database to analyze the nationwide epidemiology and clinical outcomes of NECs in Taiwan. Methods We used morphology codes from the International Classification of Diseases for Oncology, third edition (ICD‐O‐3) and ICD codes to identify the histologic type and sites of NECs, respectively. The Kaplan–Meier method was used to estimate the overall survival (OS) of NECs. The risk of NEC death was evaluated using Cox proportional hazards regression analysis. Results The incidence of NECs in Taiwan was 3.892 per 100,000 in 2006 and increased to 4.039 per 100,000 in 2021, with the predominant site being the lung and bronchus and the histologic type of SCC. The median OS of all NECs was 8.3 months. Female sex, earlier stage, and later diagnosis (2016–2021) were good prognostic factors for the OS of NECs, whereas the histologic type of SCC and large cell neuroendocrine carcinoma, primary sites of the lung and bronchus, esophagus, and unknown primary sites were poor prognostic factors for the OS of NECs. Surgery combined with chemotherapy and/or radiation therapy resulted in longer survival for stage III/IV NECs. Conclusions Differences in the incidence trends and clinical outcomes of NECs suggest different etiologies and heterogeneities of NECs. Further investigations on risk factor identification and novel treatment strategies for NECs are warranted. Differences in the incidence trends and clinical outcomes of NECs suggest different etiologies and heterogeneities of NECs. Further investigations on risk factor identification and novel treatment strategies for NECs are warranted.
Publisher
John Wiley & Sons, Inc,Wiley
Subject
/ Age
/ Aged
/ Bronchus
/ Cancer
/ Carcinoma, Neuroendocrine - epidemiology
/ Carcinoma, Neuroendocrine - mortality
/ Carcinoma, Neuroendocrine - pathology
/ Carcinoma, Neuroendocrine - therapy
/ Female
/ Females
/ high‐grade neuroendocrine carcinoma
/ Humans
/ Lung Neoplasms - epidemiology
/ Male
/ population‐based cancer registry
/ Registries - statistics & numerical data
/ Taiwan
